ติดตาม
Kevin DeBoyace
Kevin DeBoyace
ยืนยันอีเมลแล้วที่ pfizer.com - หน้าแรก
ชื่อ
อ้างโดย
อ้างโดย
ปี
The application of modeling and prediction to the formation and stability of amorphous solid dispersions
K DeBoyace, PLD Wildfong
Journal of Pharmaceutical Sciences 107 (1), 57-74, 2018
912018
Tunable thermoassociation of binary guanosine gels
Y Yu, D Nakamura, K DeBoyace, AW Neisius, LB McGown
The Journal of Physical Chemistry B 112 (4), 1130-1134, 2008
842008
Raman spectroscopy for the process analysis of the manufacturing of a suspension metered dose inhaler
J Butz, L de la Cruz, J DiTonno, K DeBoyace, G Ewing, B Donovan, ...
Journal of pharmaceutical and biomedical analysis 54 (5), 1013-1019, 2011
152011
Modeling and prediction of drug dispersability in polyvinylpyrrolidone-vinyl acetate copolymer using a molecular descriptor
K DeBoyace, IS Buckner, Y Gong, TR Ju, PLD Wildfong
Journal of Pharmaceutical Sciences 107 (1), 334-343, 2018
142018
Interpreting the physicochemical meaning of a molecular descriptor which is predictive of amorphous solid dispersion formation in polyvinylpyrrolidone vinyl acetate
K DeBoyace, M Bookwala, IS Buckner, D Zhou, PLD Wildfong
Molecular Pharmaceutics 19 (1), 303-317, 2021
102021
Predicting density of amorphous solid materials using molecular dynamics simulation
M Bookwala, K DeBoyace, IS Buckner, PLD Wildfong
AAPS PharmSciTech 21, 1-11, 2020
82020
Differential scanning calorimetry isothermal hold times can impact interpretations of drug-polymer dispersability in amorphous solid dispersions
K DeBoyace, C Zdaniewski, PLD Wildfong
Journal of pharmaceutical and biomedical analysis 150, 43-50, 2018
72018
Applications of dynamic mechanical analysis in the engineering of amorphous solid dispersions
AT Ojo, PI Lee
Pharmaceutical Fronts 2 (01), e55-e63, 2020
52020
Modeling and Prediction of Amorphous Solid Dispersion Formation Using a Molecular Descriptor
K DeBoyace
Duquesne University, 2019
22019
Metronidazole crystal patterns formed during the metamorphosis of topical carbopol gels.
S Ajjarapu, K DeBoyace, S Sarabu, VK Shankar, S Rangappa, ...
Journal of Excipients and Food Chemicals 14 (1), 44-56, 2023
12023
Crystal structure of tert-butyl 4-[4-(4-fluorophenyl)-2-methylbut-3-yn-2-yl] piperazine-1-carboxylate
A Gumireddy, K DeBoyace, A Rupprecht, M Gupta, S Patel, PT Flaherty, ...
Acta Crystallographica Section E: Crystallographic Communications 77 (4 …, 2021
12021
Solid forms of a cdk2 inhibitor
CAO Fengjuan, KF Deboyace, M Heberlein
US Patent App. 18/268,959, 2024
2024
Understanding the Influence of API Conformations on Amorphous Dispersion Formation Potential Predictions using the R3m Molecular Descriptor
K DeBoyace, M Bookwala, D Zhou, IS Buckner, PLD Wildfong
Molecular Pharmaceutics 21 (2), 770-780, 2024
2024
Drug Phase Transformation and Water Redistribution during Continuous Tablet Manufacturing: A Case Study of Carbamazepine Dihydrate
B Munjal, K DeBoyace, F Cao, JF Krzyzaniak, KK Arora, ...
Molecular pharmaceutics 20 (7), 3427-3437, 2023
2023
ระบบไม่สามารถดำเนินการได้ในขณะนี้ โปรดลองใหม่อีกครั้งในภายหลัง
บทความ 1–14